Cargando…
Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020106/ https://www.ncbi.nlm.nih.gov/pubmed/27464766 http://dx.doi.org/10.1007/s12325-016-0390-x |
_version_ | 1782453175359373312 |
---|---|
author | Hughes, Andrew Landers, Donal Arkenau, Hendrik-Tobias Shah, Saj Stephens, Richard Mahal, Amrik Simmons, Matthew Lemech, Charlotte Royle, Jennifer |
author_facet | Hughes, Andrew Landers, Donal Arkenau, Hendrik-Tobias Shah, Saj Stephens, Richard Mahal, Amrik Simmons, Matthew Lemech, Charlotte Royle, Jennifer |
author_sort | Hughes, Andrew |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5020106 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-50201062016-09-27 Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT Hughes, Andrew Landers, Donal Arkenau, Hendrik-Tobias Shah, Saj Stephens, Richard Mahal, Amrik Simmons, Matthew Lemech, Charlotte Royle, Jennifer Adv Ther Erratum Springer Healthcare 2016-07-27 2016 /pmc/articles/PMC5020106/ /pubmed/27464766 http://dx.doi.org/10.1007/s12325-016-0390-x Text en © The Author(s) 2016 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Erratum Hughes, Andrew Landers, Donal Arkenau, Hendrik-Tobias Shah, Saj Stephens, Richard Mahal, Amrik Simmons, Matthew Lemech, Charlotte Royle, Jennifer Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT |
title | Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT |
title_full | Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT |
title_fullStr | Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT |
title_full_unstemmed | Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT |
title_short | Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT |
title_sort | erratum to: development and evaluation of a new technological way of engaging patients and enhancing understanding of drug tolerability in early clinical development: proact |
topic | Erratum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020106/ https://www.ncbi.nlm.nih.gov/pubmed/27464766 http://dx.doi.org/10.1007/s12325-016-0390-x |
work_keys_str_mv | AT hughesandrew erratumtodevelopmentandevaluationofanewtechnologicalwayofengagingpatientsandenhancingunderstandingofdrugtolerabilityinearlyclinicaldevelopmentproact AT landersdonal erratumtodevelopmentandevaluationofanewtechnologicalwayofengagingpatientsandenhancingunderstandingofdrugtolerabilityinearlyclinicaldevelopmentproact AT arkenauhendriktobias erratumtodevelopmentandevaluationofanewtechnologicalwayofengagingpatientsandenhancingunderstandingofdrugtolerabilityinearlyclinicaldevelopmentproact AT shahsaj erratumtodevelopmentandevaluationofanewtechnologicalwayofengagingpatientsandenhancingunderstandingofdrugtolerabilityinearlyclinicaldevelopmentproact AT stephensrichard erratumtodevelopmentandevaluationofanewtechnologicalwayofengagingpatientsandenhancingunderstandingofdrugtolerabilityinearlyclinicaldevelopmentproact AT mahalamrik erratumtodevelopmentandevaluationofanewtechnologicalwayofengagingpatientsandenhancingunderstandingofdrugtolerabilityinearlyclinicaldevelopmentproact AT simmonsmatthew erratumtodevelopmentandevaluationofanewtechnologicalwayofengagingpatientsandenhancingunderstandingofdrugtolerabilityinearlyclinicaldevelopmentproact AT lemechcharlotte erratumtodevelopmentandevaluationofanewtechnologicalwayofengagingpatientsandenhancingunderstandingofdrugtolerabilityinearlyclinicaldevelopmentproact AT roylejennifer erratumtodevelopmentandevaluationofanewtechnologicalwayofengagingpatientsandenhancingunderstandingofdrugtolerabilityinearlyclinicaldevelopmentproact |